Schizophrenia Research
Volume 77, Issue 2 , Pages 129-139, 15 September 2005

An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: Results from a long-term study

Medical Affairs Division, Janssen Pharmaceutica Products, L.P., 1125 Trenton-Harbourton Road, Titusville, NJ 08560-0200, USA

Received 18 November 2004; received in revised form 15 March 2005; accepted 17 March 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-9964(05)00125-8

doi:10.1016/j.schres.2005.03.015

Schizophrenia Research
Volume 77, Issue 2 , Pages 129-139, 15 September 2005

Article Tools

* Image Usage & Resolution